Edward M. Basile, Director at TransMedics Group, Inc. (TMDX), sold 13,500 shares at $84.30 ($1.1M) on 2024-11-05, disclosed to the SEC on 2024-11-07.
Scheduled sale ($1.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.35 | 5,296 | $441K | 39.1% |
| 2 | $83.35 | 5,296 | $441K | 39.1% |
| 3 | $84.30 | 1,454 | $123K | 10.9% |
| 4 | $84.30 | 1,454 | $123K | 10.9% |
| Total | $83.55 avg | 13,500 | $1.1M | 100% |
| Filing → |
| TMDX | SELL | 2025-05-29 | $632K | — | Filing → |
| TMDX | SELL | 2025-05-13 | $694K | — | Filing → |
| TMDX | SELL | 2024-08-08 | $1.9M | — | Filing → |